Nanomedical Strategies for Kidney Disease: Diagnostic Innovations and Therapeutic Advancements
Advanced Healthcare Materials · 2025-07 · 14 (18)
DOI: 10.1002/adhm.202500657 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Healthcare Materials, online erschienen am 23.05.2025. Verfasst von Fengyang Yao und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Shanxi Medical University, Taiyuan, 030001, China. Hauptthemen laut MEDLINE: Kidney Diseases, Nanomedicine. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 187 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Key Laboratory of Nano-imaging and Drug-loaded Preparation of Shanxi Province, Shanxi Province Basic Research Program for Young Scientific Research Projects.
Abstract (Originalsprache)
Kidney diseases, posing significant global public health challenges due to their complex pathogenesis and diagnostic/therapeutic difficulties, have seen emerging advancements through nanomedicine. In diagnostics, nanoparticles leverage unique physicochemical properties to enhance imaging precision. Superparamagnetic iron oxide nanoparticles improve magnetic resonance imaging sensitivity by amplifying T 2 ‐weighted contrast, while microbubbles/nanobubbles enhance ultrasound resolution via signal reflection. Quantum dots and gold nanoparticles optimize photoacoustic imaging with superior fluorescence and photostability. Therapeutically, nanoparticle‐based drug delivery systems demonstrate targeted delivery, reduced systemic toxicity, and improved drug stability and bioavailability in preclinical studies. Nanocarrier‐integrated stem cell and gene therapies further show potential in repairing renal cells and mitigating kidney injury. This review systematically examines nanomedicine's dual diagnostic and therapeutic roles in kidney diseases, compares strengths and limitations of various nanodelivery platforms, and addresses current challenges in clinical translation. By exploring novel nanotechnology‐driven strategies, it aims to guide future research toward effective, tailored therapies for improved renal disease management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Basic Medical Sciences, Shanxi Medical University, Taiyuan, 030001, China.
- Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical University, Tongji Shanxi Hospital, Taiyuan, 030032, China.
- Shanxi Academy of Advanced Research and Innovation (SAARl), Taiyuan, 030032, China.
- School of Pharmacy, Shanxi Medical University, Taiyuan, 030001, China.
- The First Clinical Medical School, Shanxi Medical University, Taiyuan, 030001, China.
- Institute of Medical Technology, Shanxi Medical University, Taiyuan, 030001, China.
ORCID-Profile: Wei Sang, Ruiping Zhang
Förderung
- National Natural Science Foundation of China
- Key Laboratory of Nano-imaging and Drug-loaded Preparation of Shanxi Province
- Shanxi Province Basic Research Program for Young Scientific Research Projects
- Key Technologies Research and Development Program
Zitieren
APA
Yao, F., Gao, W., Li, L., Huang, Y., Sang, W., & Zhang, R. (2025). Nanomedical Strategies for Kidney Disease: Diagnostic Innovations and Therapeutic Advancements. Advanced Healthcare Materials, 14(18). https://doi.org/10.1002/adhm.202500657
Vancouver
Yao F, Gao W, Li L, Huang Y, Sang W, Zhang R. Nanomedical Strategies for Kidney Disease: Diagnostic Innovations and Therapeutic Advancements. Advanced Healthcare Materials. 2025;14(18). doi:10.1002/adhm.202500657
BibTeX
@article{Yao2025,
author = {Yao, Fengyang and Gao, Weiqi and Li, Limeng and Huang, Yijun and Sang, Wei and Zhang, Ruiping},
title = {Nanomedical Strategies for Kidney Disease: Diagnostic Innovations and Therapeutic Advancements},
journal = {Advanced Healthcare Materials},
year = {2025},
volume = {14},
number = {18},
doi = {10.1002/adhm.202500657}
}
EUVIMED